Regeneron Pharmaceuticals (REGN) Construction in Progress (2013 - 2017)

Regeneron Pharmaceuticals' Construction in Progress history runs 5 years deep, the most recent figure standing at $408.9 million for Q4 2017.

• In Q4 2017, Construction in Progress rose 28.2% year-over-year to $408.9 million; the TTM figure through Dec 2017 stood at $408.9 million (up 28.2% YoY), while the FY2017 annual figure was $408.9 million, up 28.2% from the prior year.
• Construction in Progress was $408.9 million for Q4 2017 at Regeneron Pharmaceuticals, up from $318.9 million in the prior quarter.
• In the past five years, Construction in Progress ranged from a high of $579.8 million in Q4 2015 to a low of $142.4 million in Q4 2013.
• Historically, Construction in Progress has averaged $384.4 million across 5 years, with a median of $408.9 million in 2017.
• The sharpest annual moves came in 2014 and 2016: Construction in Progress jumped 231.69% in 2014, then plunged 45.0% in 2016.
• A 5-year view of Construction in Progress shows it stood at $142.4 million in 2013, then surged by 231.69% to $472.2 million in 2014, then gained by 22.79% to $579.8 million in 2015, then slumped by 45.0% to $318.9 million in 2016, then advanced by 28.2% to $408.9 million in 2017.
• The last three Construction in Progress figures came in at $408.9 million (Q4 2017), $318.9 million (Q4 2016), and $579.8 million (Q4 2015), per Business Quant data.